Pharma IQ
Codeine response varies by metabolizer status, with ultra-rapid metabolizers needing more and poor metabolizers risking accumulation at full doses. Metabolizer phenotype affects dosing and toxicity risk. CYP450 enzyme activity in the liver…
1 sources - 5 claims
Codeine response varies by metabolizer status, with ultra-rapid metabolizers needing more and poor metabolizers risking accumulation at full doses. Metabolizer phenotype affects dosing and toxicity risk. CYP450 enzyme activity in the liver is the central mechanism used to assess drug metabolism. A red drug flag can indicate genetically elevated adverse-effect risk even in a normal metabolizer. Pharma IQ uses pharmacogenomics to match medications to a patient's genetic makeup.